IGF2BP3, an m6A reader, facilitates macrophage infiltration and M2 polarization by upregulating the expression of CCL5 and transforming growth factor beta 1 (TGF‐β1), which, in turn, inhibits CD8+ T cell activation and contributes to the progression of liver cancer. Here, IGF2BP3 is linked to liver cancer.